Hormone replacement therapy in systemic lupus erythematosus

Journal of Rheumatology

Volumn 24, Issue 11, 1997, Pages 2149-2152

  Kreidstein, Sharon ^a,b   Urowitz, Murray B ^a,b,c,d   Gladman, Dafna D ^a,b,c   Gough, Jacqueline ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Ctr Prognosis Studs Rheum Dis   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Disease activity; Hormone therapy; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ACUTE DISEASE; DISEASE PROGRESSION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POSTMENOPAUSE;

EID: 0030693995     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Grady D. Rubin SM, Petitti DB, et al: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
2. Rubin LA, Urowitz MB, Gladman DD: Mortality in SLE: The bimodal pattern revisited. Q J Med 1985;216:87-98.
3. Petri M, Perez-Gutthann S, Spence D, Hochberg MC: Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-9.
4. Ahmed AS, Dauphinee MJ, Talal N: Effects of short-term administration of sex hormones on normal and autoimmune mice. J Immunol 1985;134:204-10.
5. Paavonen T, Andersson LC, Adlercreutz H: Sex hormone regulation of in vitro immune response: Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen stimulated cultures. J Exp Med 1980;154:1935-45.
6. Lahita RG: Sex steroids and the rheumatic diseases. Arthritis Rheum 1980;28:121-6.
7. Raveche ES, Tjio JH, Boegel W, Steinberg AD: Studies of the effects of sex hormones on autosomal and x-linked genetic control of induced and spontaneous antibody production. Arthritis Rheum 1979;22:1177-87.
8. Roubinian JR, Talal N, Siiteri PK. Sadakian JA: Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum 1979;22:1162-9.
9. Steinberg AD, Melez KA, Raveche ES, et al: Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum 1979;22:1170-6.
10. Talal N: Sex steroid hormones and systemic lupus erythematosus. Arthritis Rheum 1981;21:1054-60.
11. Asherson RA, Harris EN, Hughes GRV: Complications of oral contraceptives and antiphospholipid antibodies (letter). Arthritis Rheum 1988;31:575-6.
12. Garovich M, Agudelo C, Pisko E: Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 1980;23:1396-8.
13. Bole GG, Friedlander MH, Smith CK: Rheumatic symptoms and serologic abnormalities induced by oral contraceptives. Lancet 1969;1:323-6.
14. Travers RL, Hughes GRV: Oral contraceptive therapy and systemic lupus erythematosus. J Rheumatol 1978;5:448-51.
15. Jungers P, Dougados M, Pelissier C, et al: Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 1982;25:618-23.
16. Barrett C, Neylor N, Snaith M: Oestrogen-induced systemic lupus erythematosus. Br J Rheumatol 1986;25:300-1.
17. Arden NK, Lloyd ME, Spector TD, Hughes GRV: Safety of hormone replacement therapy in systemic lupus erythematosus. Lupus 1994;3:11-3.
18. Bombardier C, Gladman DD, Urowitz MB, Chang CH, The Committee on Prognosis in SLE: Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
19. Gladman DD, Goldsmith CH, Urowitz M, et al: Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: International validation. J Rheumatol 1994;21:1468-71.
20. Breslow NE, Day NE: Statistical methods in cancer research, vol 1. The analysis of case control studies. New York: Oxford University Press, 1980.
21. Lahita RG: The importance of estrogens in systemic lupus erythematosus. Immunol Immunopathol 1992;63:17-8.
22. Julkunen HA, Kaaja R, Friman C: Contraceptive practises in women with systemic lupus erythematosus. Br J Rheumatol 1993;32:227-30.
23. Lockshin MD: Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989;32:665-70.
24. Mintz G, Niz J, Gutierrez G, Garcia-Alfonso A, Karchner S: Prospective study of pregnancy in systemic lupus erythematosus: Results of a multidisciplinary approach. J Rheumatol 1986;13:732-9.
25. Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D: Lupus pregnancy case control study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 1984;77:893-8.
26. Petri M, Howard D, Repke J: Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991;34:1538-45.
27. Ruiz-Irastorza G, Lima F, Alves MA, et al: Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies. Br J Rheumatol 1996;35:133-8.
28. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J: Lupus and pregnancy studies. Arthritis Rheum 1993;36:1392-7.
29. Sanchez-Guerrero J, Liam MH, Karlson EW, Hunter DJ, Colditz GA: Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 1995;122:430-3.
30. Buyon JP, Abramson S, Belmont M: Past and present usage of oral contraceptives and hormonal replacement in women with SLE (abstr). Arthritis Rheum 1993;36:S229.
31. McLaughlin J, Gladman D, Urowitz M, Bombardier C, Farewell V, Cole E: Kidney biopsy in SLE. II. Survival analyses according to biopsy results. Arthritis Rheum 1991;10:1268-73.